1.Gene Transfer into Cultured Cardiac Myocytes Mediated by Retrovirus.
Jeong Eun HUH ; Duk Kyung KIM ; Jong Hoe BYUN ; Sun Jin PARK ; Eun Suk JEON ; Yoon Hyuk CHOE ; Eun A JUNG ; Hyeon Cheol GWON ; Seung Woo PARK ; June Soo KIM ; Sang Hoon LEE ; Kyung Pyo HONG ; Jeong Euy PARK ; Francois Loic COSSET ; Jung Don SEO ; Won Ro LEE
Korean Circulation Journal 1999;29(2):182-191
BACKGROUND: Transplantation of cardiac myocytes (CMs) into the injured heart emerges as a potential alternative for the treatment of heart failure. Genetic modification of CMs could enhance and/or modify its therapeutic effects. The characteristics of retroviral gene delivery, which is most commonly used in human trial, has been minimally studied in CMs due to its low efficiency in non-dividing cells. In this study, using newly developed high-titer retrovirus, we evaluated 1) the efficiency of gene transfer into CMs, 2) whether S phase during infection is necessary for the transduction, and 3) characteristics of gene delivery to mononucleated vs binucleated CMs. METHODS: Enriched CMs were cultured from the ventricles of 1 day-old rat hearts. The cells were transduced by MFG-nls-LacZ retroviruses (5x107 IU/ml) in the presence or absence of polybrene. 3H-thymidine was added to label cells in S phase. The cells were stained for
Animals
;
Autoradiography
;
Cells, Cultured
;
Dichlorodiphenyldichloroethane
;
Genetic Therapy
;
Heart
;
Heart Failure
;
Hexadimethrine Bromide
;
Humans
;
Myocytes, Cardiac*
;
Rats
;
Retroviridae*
;
S Phase
;
Thymidine
;
Zidovudine